Alector (ALEC) stock drops after a Phase 3 trial failure for a dementia drug it was developing with GSK (GSK). Read more here ...

GlaxoSmithKline ( ($GB:GSK) ) has provided an announcement. GSK has announced positive results from its phase III clinical trials for a ...

Drugmaker GSK released two sets of trial data on Wednesday, covering its low-carbon asthma inhaler and a potential new ...

New survey shows nearly 70% of older adults in Singapore underestimate their risk of shingles; only 1 in 4 plans to consult ...

GSK & Spero announce positive PIVOT-PO phase III trial of tebipenem HBr, an investigational oral treatment for complicated urinary tract infections: London, UK Wednesday, October ...

Aurinia Pharmaceuticals has strong Lupkynis sales, robust pipeline, and financial health drive growth. See why we rate AUPH ...

(Alliance News) - GSK PLC and Nasdaq-listed Alector Inc on Wednesday said they won't proceed with a study into a possible dementia treatment after trial results failed to meet hopes. The Infront-3 ...

EMA committee issues positive opinion to support the approval of GSK’s recombinant zoster vaccine, Shingrix in a prefilled syringe: London, UK Wednesday, October 22, 2025, 16:00 ...

Wednesday, October 22, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Oracle ...

Sudden cuts to U.S. global health aid this year have hit Atlanta-based international nonprofits hard, spurring layoffs of close to 1,000 workers, and imperiling their mission to help millions of ...

The UK's FTSE 100 index closed Wednesday 0.93% in the green following the latest inflation report and earnings from major ...

Leading YES Foundation, Garima Dutt is shaping scalable youth skilling and sustainable livelihoods with measurable social ...